# The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire

> **NCT00901004** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1550 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00901004
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** —
- **Final completion:** 2009-09
- **Target enrollment:** 1550 (ACTUAL)
- **Last updated:** 2010-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00901004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00901004, "The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00901004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*